Get the Stockscreener App
128.87
0.48%
0.65
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Abbott Laboratories stock is traded at $128.87, with a volume of 844.06K.
It is up +0.48% in the last 24 hours and up +13.61% over the past month.
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
See More
Previous Close:
$128.22
Open:
$128.07
24h Volume:
844.06K
Relative Volume:
0.16
Market Cap:
$222.39B
Revenue:
$41.95B
Net Income/Loss:
$13.40B
P/E Ratio:
16.85
EPS:
7.65
Net Cash Flow:
$6.49B
1W Performance:
+0.70%
1M Performance:
+13.61%
6M Performance:
+17.18%
1Y Performance:
+13.70%
1-Day Range:
$128.07
$129.49
1-Week Range:
$126.00
$132.50
52-Week Range:
$99.71
$132.50
Abbott Laboratories Stock (ABT) Company Profile
Name
Abbott Laboratories
Sector
Industry
Phone
(224) 667-6100
Address
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
Compare ABT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ABT
Abbott Laboratories
|
128.84 | 222.39B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
105.25 | 154.78B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
392.68 | 150.99B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
90.19 | 116.46B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
71.33 | 41.87B | 6.60B | 4.16B | 490.10M | 6.93 |
Abbott Laboratories Stock (ABT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-08-24 | Initiated | Oppenheimer | Outperform |
| Sep-19-24 | Initiated | Piper Sandler | Overweight |
| Jul-30-24 | Downgrade | Edward Jones | Buy → Hold |
| May-30-24 | Initiated | Goldman | Buy |
| Jul-21-23 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| May-30-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-20-23 | Reiterated | Barclays | Overweight |
| Apr-20-23 | Reiterated | Bernstein | Outperform |
| Apr-20-23 | Reiterated | JP Morgan | Overweight |
| Apr-20-23 | Reiterated | Raymond James | Outperform |
| Apr-20-23 | Reiterated | UBS | Buy |
| Apr-20-23 | Reiterated | Wolfe Research | Underperform |
| Mar-29-23 | Initiated | UBS | Buy |
| Oct-26-22 | Initiated | Mizuho | Neutral |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jul-06-22 | Initiated | Wolfe Research | Underperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-27-22 | Reiterated | Credit Suisse | Outperform |
| Jan-27-22 | Reiterated | Morgan Stanley | Overweight |
| Jan-27-22 | Reiterated | Raymond James | Outperform |
| Jan-27-22 | Reiterated | UBS | Buy |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| Oct-27-21 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Oct-14-21 | Initiated | Redburn | Neutral |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-15-21 | Initiated | Atlantic Equities | Neutral |
| Jan-28-21 | Upgrade | BTIG Research | Neutral → Buy |
| Sep-11-20 | Initiated | Wolfe Research | Outperform |
| Jun-01-20 | Downgrade | Goldman | Neutral → Sell |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Neutral |
| Feb-06-20 | Resumed | BTIG Research | Neutral |
| Jan-02-20 | Downgrade | Guggenheim | Buy → Neutral |
| Jun-13-19 | Reiterated | BofA/Merrill | Buy |
| Feb-07-19 | Reiterated | BofA/Merrill | Buy |
| Jan-02-19 | Downgrade | Citigroup | Neutral → Sell |
| Nov-30-18 | Upgrade | Goldman | Neutral → Buy |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Jun-27-18 | Initiated | Bernstein | Outperform |
| Jan-30-18 | Reiterated | Citigroup | Neutral |
| Jan-25-18 | Reiterated | Stifel | Buy |
| Jan-25-18 | Upgrade | William Blair | Mkt Perform → Outperform |
| Jan-03-18 | Initiated | Evercore ISI | Outperform |
| Jan-02-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Jan-02-18 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-19-17 | Reiterated | RBC Capital Mkts | Outperform |
| Oct-19-17 | Reiterated | Stifel | Buy |
View All
Abbott Laboratories Stock (ABT) Latest News
Are Wall Street Analysts Bullish On Abbott Laboratories Stock? - Barchart
Are Wall Street Analysts Bullish on Abbott Laboratories Stock? - TradingView
Abbott Laboratories (NYSE:ABT) Shares Bought by Sumitomo Mitsui Trust Group Inc. - MarketBeat
RNC Capital Management LLC Reduces Stock Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Jim Cramer on Lawsuit Against Abbott Laboratories (ABT): ‘Dismiss It, Not Worry About It’ - Yahoo Finance
Trust Point Inc. Buys 3,876 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
U.S. Capital Wealth Advisors LLC Boosts Stock Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
HHM Wealth Advisors LLC Increases Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Tells Judge To Keep Formula Cases In Federal Court - Law360
Welch Group LLC Purchases 3,479 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Carotid Stent Market Size, Share, Forecast (2024-2031) | Abbott - openPR
Medical Disposables Market Projected To Witness Substantial Growth, 2025-2032 | Abbott laboratories, Johnson - EIN News
YANKCOM Partnership Takes $1.27 Million Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Bleakley Financial Group LLC Acquires 10,983 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories Clears Key Benchmark, Hitting 80-Plus RS Rating - Investor's Business Daily
Abbott Laboratories stock outperforms competitors on strong trading day - MarketWatch
Abbott Laboratories (NYSE:ABT) Shares Acquired by Confluence Wealth Services Inc. - MarketBeat
Stratos Wealth Partners LTD. Sells 3,446 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
2,898 Shares in Abbott Laboratories (NYSE:ABT) Acquired by Hager Investment Management Services LLC - MarketBeat
Does Abbott Laboratories (NYSE:ABT) Deserve A Spot On Your Watchlist? - Simply Wall St
Yousif Capital Management LLC Sells 8,745 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Retirement Systems of Alabama Has $42.48 Million Stock Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Sargent Investment Group LLC Sells 15,401 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Short Interest in Abbott Laboratories (NYSE:ABT) Rises By 18.3% - MarketBeat
70% of People with Diabetes Feel Stigma: Abbott Survey Reveals Challenges - HIT Consultant
Elon Musk's X sues Lego, Shell, more companies over advertising 'boycott' from platform - USA TODAY
Abbott's 'Above the Bias' Film Reveals Misconceptions Can Impact Diabetes Care -February 04, 2025 at 11:27 am EST - Marketscreener.com
Abbott's 'Above the Bias' Film Reveals Misconceptions Can Impact Diabetes Care – Company Announcement - Financial Times
Abbott Laboratories Included in Musk's Advertising Lawsuit - MD+DI
Abbott Laboratories (NYSE:ABT) Shares Sold by Cullinan Associates Inc. - MarketBeat
abrdn plc Acquires 37,578 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Invest with Confidence: Intrinsic Value Unveiled of Abbott Labor - GuruFocus.com
Invest with Confidence: Intrinsic Value Unveiled of Abbott Laboratories - Yahoo Finance
Alliance Wealth Advisors LLC UT Has $3.62 Million Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Sen. Markwayne Mullin Unloads Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Greenleaf Trust Has $10.84 Million Stock Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Heck Capital Advisors LLC Purchases Shares of 7,830 Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Shares Sold by Cibc World Market Inc. - MarketBeat
Caprock Group LLC Raises Stock Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
China Universal Asset Management Co. Ltd. Grows Stock Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Jennison Associates LLC Increases Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Clinical Laboratory Services Market Set to Witness Significant Growth by 2025-2032: Abbott Laboratories, - EIN News
Stock Yards Bank & Trust Co. Sells 16,371 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Shares Bought by Golden State Equity Partners - MarketBeat
Abbott Laboratories (NYSE:ABT) Shares Sold by OLD National Bancorp IN - MarketBeat
Elon Musk’s X sues these big companies over ‘collective advertising boycott’ claims - The Times of India
Robeco Institutional Asset Management B.V. Buys 235,790 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Why Abbott Laboratories (ABT) Is Among the Best Cancer Stocks to Buy According to Hedge Funds - Yahoo Finance
Chicago Partners Investment Group LLC Raises Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
2,548 Shares in Abbott Laboratories (NYSE:ABT) Purchased by Orca Wealth Management LLC - MarketBeat
Elon Musk's X sues these companies for collective ad boycotting: Report - Hindustan Times
Abbott Laboratories Stock (ABT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.20%
0.69%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):